Although further research is needed to define mAb 13F4’s inhibitory mechanism, this study demonstrates that Ssa1 inhibition by mAb 13F4 can prevent C. albicans adherence to and “subversion” of host epithelial cells, offering a promising novel therapeutic approach for invasive fungal infections. Here, TRIM21 is linked to fungal infectious disease.